Source: 4-traders

Aum Lifetech: AUM LifeTech, CHOP and Penn Partnering to Advance Cancer Immunotherapy Against Lung Cancer Using Foxp3 Gene Silencing FANA ASO Therapy

(marketscreener.com) AUM LifeTech, Inc., a Philadelphia-based biotech company, has partnered with the Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania to employ next-generation RNA silencing FANA technology as a new approach to cancer immunotherapy designed to...http://www.marketscreener.com/news/AUM-LifeTech-CHOP-and-Penn-Partnering-to-Advance-Cancer-Immunotherapy-Against-Lung-Cancer-Using-Fox--27398855/?utm_medium=RSS&utm_content=20181010

Read full article »
Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



Aum Lifetech is a Private company. Aum Lifetech has an estimated revenue of <$1M and an estimate of less <10 employees.